Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
1.625
+0.065 (4.17%)
Aug 13, 2025, 4:00 PM - Market closed
Erasca Market Cap
Erasca has a market cap or net worth of $459.51 million as of August 14, 2025. Its market cap has decreased by -48.13% in one year.
Market Cap
459.51M
Enterprise Value
99.25M
1-Year Change
-48.13%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $459.51M, a decrease of -75.27%. That is a compound annual growth rate of -29.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 459.51M | -35.25% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |